Oxidative stress in ALS: key role in motor neuron injury and therapeutic target
- PMID: 19969067
- DOI: 10.1016/j.freeradbiomed.2009.11.018
Oxidative stress in ALS: key role in motor neuron injury and therapeutic target
Abstract
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder characterized by death of motor neurons leading to muscle wasting, paralysis, and death, usually within 2-3 years of symptom onset. The causes of ALS are not completely understood, and the neurodegenerative processes involved in disease progression are diverse and complex. There is substantial evidence implicating oxidative stress as a central mechanism by which motor neuron death occurs, including elevated markers of oxidative damage in ALS patient spinal cord and cerebrospinal fluid and mutations in the antioxidant enzyme superoxide dismutase 1 (SOD1) causing approximately 20% of familial ALS cases. However, the precise mechanism(s) by which mutant SOD1 leads to motor neuron degeneration has not been defined with certainty, and the ultimate trigger for increased oxidative stress in non-SOD1 cases remains unclear. Although some antioxidants have shown potential beneficial effects in animal models, human clinical trials of antioxidant therapies have so far been disappointing. Here, the evidence implicating oxidative stress in ALS pathogenesis is reviewed, along with how oxidative damage triggers or exacerbates other neurodegenerative processes, and we review the trials of a variety of antioxidants as potential therapies for ALS.
(c) 2009 Elsevier Inc. All rights reserved.
Similar articles
-
Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1051-67. doi: 10.1016/j.bbadis.2006.03.008. Epub 2006 Apr 4. Biochim Biophys Acta. 2006. PMID: 16713195 Review.
-
Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.Brain. 2005 Jul;128(Pt 7):1686-706. doi: 10.1093/brain/awh503. Epub 2005 May 4. Brain. 2005. PMID: 15872021
-
Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.Neuroscience. 2007 Feb 9;144(3):991-1003. doi: 10.1016/j.neuroscience.2006.09.064. Epub 2006 Dec 5. Neuroscience. 2007. PMID: 17150307 Free PMC article.
-
Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.J Neurochem. 2007 Aug;102(3):609-18. doi: 10.1111/j.1471-4159.2007.04502.x. Epub 2007 Mar 23. J Neurochem. 2007. PMID: 17394531
-
ALS: a disease of motor neurons and their nonneuronal neighbors.Neuron. 2006 Oct 5;52(1):39-59. doi: 10.1016/j.neuron.2006.09.018. Neuron. 2006. PMID: 17015226 Review.
Cited by
-
N-terminal cleavage of the mitochondrial fusion GTPase OPA1 occurs via a caspase-independent mechanism in cerebellar granule neurons exposed to oxidative or nitrosative stress.Brain Res. 2013 Feb 4;1494:28-43. doi: 10.1016/j.brainres.2012.12.001. Epub 2012 Dec 7. Brain Res. 2013. PMID: 23220553 Free PMC article.
-
The peroxisome proliferator-activated receptor γ (PPARγ) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis.J Biol Chem. 2012 Oct 19;287(43):35899-911. doi: 10.1074/jbc.M112.366419. Epub 2012 Aug 21. J Biol Chem. 2012. PMID: 22910911 Free PMC article.
-
MicroRNA-137-3p Protects PC12 Cells Against Oxidative Stress by Downregulation of Calpain-2 and nNOS.Cell Mol Neurobiol. 2021 Aug;41(6):1373-1387. doi: 10.1007/s10571-020-00908-0. Epub 2020 Jun 27. Cell Mol Neurobiol. 2021. PMID: 32594381
-
Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients.Int J Mol Sci. 2021 May 26;22(11):5673. doi: 10.3390/ijms22115673. Int J Mol Sci. 2021. PMID: 34073630 Free PMC article.
-
Blood-Brain Barrier Disruption and Its Involvement in Neurodevelopmental and Neurodegenerative Disorders.Int J Mol Sci. 2022 Dec 3;23(23):15271. doi: 10.3390/ijms232315271. Int J Mol Sci. 2022. PMID: 36499600 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous